hydroxypropyl tetrahydropyrantriol
Tetrahydropyran (THP) is the organic compound consisting of a saturated six-membered ring containing five carbon atoms and one oxygen atom. It is named by reference to pyran, which contains two double bonds, and may be produced from it by adding four hydrogens. In 2013, its preferred IUPAC name was established as oxane. The compound is a colourless volatile liquid. Derivatives of tetrahydropyran are, however, more common. 2-Tetrahydropyranyl (THP-) ethers derived from the reaction of alcohols and 3,4-dihydropyran are commonly used as protecting groups in organic synthesis. Furthermore, a tetrahydropyran ring system, i.e., five carbon atoms and an oxygen, is the core of pyranose sugars, such as glucose. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Earliest trial started Aug 1, 2006 (NCT00403702)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTetrahydropyran ↗
Also known as
- hydroxypropyltetrahydropyrantriol
- hydroxypropyl tetrahydropyrantriol
- oxane
- oxane
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00818545 | N/A | Nov 1, 2007 | L'Oreal, Paris Diderot University |
| NCT00403702 | Phase 2/Phase 3 (Phase 3) | Aug 1, 2006 | Asociación para Evitar la Ceguera en México |
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asociación para Evitar la Ceguera en México | Academic/Hospital | 1 | 1 | 1 | 2006 |
| L'Oreal | For profit | 1 | 1 | 1 | 2007 |
| Paris Diderot University | Academic/Hospital | 1 | 0 | 1 | 2007 |